Aims To assess cytokine levels in peripheral blood and tears of patients after allogeneic haematopoietic stem cell ...
News-Medical.Net on MSN
Researchers develop tool to predict how patients will respond to common multiple sclerosis drug
Brazilian researchers, in partnership with French institutions, have developed a tool that can predict how patients will ...
Discover Google’s Gemma 3, a groundbreaking multimodal AI transforming education, accessibility, and creativity with ...
23hon MSN
Machine learning and cell imaging combine to predict effectiveness of multiple sclerosis medication
Brazilian researchers, in partnership with French institutions, have developed a tool that can predict how patients will respond to natalizumab, one of the most commonly used drugs for treating ...
Brand Authenticity, Generation Z, Consumer Loyalty, Digital Engagement, Structural Equation Modeling, Emerging Markets, Ghana ...
National AI usage among businesses is 9.2%, with a projected increase to 11.6% in six months. Utah leads state AI business adoption at 15.7%%; Delaware's projected rate is highest at 19.1%.
The latest price target for Palantir Technologies (NASDAQ:PLTR) was reported by B of A Securities on September 23, 2025. The analyst firm set a price target for $215.00 expecting PLTR to rise to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback